Chronic Progressive Multiple Sclerosis

A form of multiple sclerosis characterized by a progressive deterioration in neurologic function which is in contrast to the more typical relapsing remitting form. If the clinical course is free of distinct remissions, it is referred to as primary progressive multiple sclerosis. When the progressive decline is punctuated by acute exacerbations, it is referred to as progressive relapsing multiple sclerosis. The term secondary progressive multiple sclerosis is used when relapsing remitting multiple sclerosis evolves into the chronic progressive form. (From Ann Neurol 1994;36 Suppl:S73-S79; Adams et al., Principles of Neurology, 6th ed, pp903-914)

Also Known As:

Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Primary Progressive; Multiple Sclerosis, Secondary Progressive; Primary Progressive Multiple Sclerosis; Progressive Relapsing Multiple Sclerosis; Remittent Progressive Multiple Sclerosis; Secondary Progressive Multiple Sclerosis; Multiple Sclerosis, Progressive Relapsing; Multiple Sclerosis, Remittent Progressive

Nervous System Diseases: 14178
- Demyelinating Diseases: 9131
  - CNS Demyelinating Autoimmune Diseases
    - Multiple Sclerosis: 35483
      - Chronic Progressive Multiple Sclerosis: 769
- Autoimmune Diseases of the Nervous System: 1461
  - CNS Demyelinating Autoimmune Diseases
    - Multiple Sclerosis: 35483
      - Chronic Progressive Multiple Sclerosis: 769
Immune System Diseases: 4321
- Autoimmune Diseases: 34618
  - Autoimmune Diseases of the Nervous System: 1461
    - CNS Demyelinating Autoimmune Diseases
      - Multiple Sclerosis: 35483
        Chronic Progressive Multiple Sclerosis: 769
Signs and Symptoms Pathological Conditions
- Pathologic Processes: 10023
  - Disease Attributes: 18
    - Chronic Disease: 25762
      - Chronic Progressive Multiple Sclerosis: 769

Y Benesova Selected Research

Y Benesova Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure